Laboratory values indicated that the post‐SVR/HCC group had a higher median MELD score, higher AST/ALT ratio, higher total bilirubin, lower albumin, and lower platelet counts, reflecting more advanced liver disease (Table 3). The gene discussed is GPT; the disease is hepatocellular carcinoma.